EVAX ▼ -2.3% - Evaxion A/S
$EVAX - Evaxion will present new target validation data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia at ASH 2026 Meeting
04-NOV-2026 09:00 AM ET
Share this post
More filings for $EVAX
EVAX ▼ -1.4% - Evaxion A/SNov 3, 2026EVAX ▼ -2.2% - Evaxion A/SOct 23, 2026EVAX ▲ +15.7% - Evaxion A/SOct 19, 2026EVAX ▲ +4.1% - Evaxion A/SOct 2, 2026EVAX ▲ +1.9% - Evaxion A/SSep 14, 2026
View full $EVAX filing history →💬 Comments
Loading comments…
Leave a comment